Worldwide Withdrawal of VIOXX (rofecoxib)
Merck News Item
Sept. 30, 2004 - Merck &. Co., Inc. today announced a voluntary worldwide withdrawal of VIOXX® (rofecoxib), its arthritis and acute pain medication. The company's decision, which is effective immediately ... due to an increased risk of cardiovascular event and stroke.
posted by McFox :: Link
0 Comments:
Post a Comment
<;p class="comment-timestamp"> << Home